US Stock MarketDetailed Quotes
MAIA MAIA Biotechnology
- 2.690
- +0.230+9.35%
Close Apr 24 16:00 ET
55.36MMarket Cap-1805P/E (TTM)
2.720High2.390Low397.71KVolume2.450Open2.460Pre Close1.04MTurnover2.63%Turnover RatioLossP/E (Static)20.58MShares3.07052wk High116.96P/B40.69MFloat Cap0.82052wk Low--Dividend TTM15.13MShs Float9.640Historical High--Div YieldTTM13.42%Amplitude0.820Historical Low2.602Avg Price1Lot Size
About MAIA Biotechnology Company
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Company Profile
SymbolMAIA
Company NameMAIA Biotechnology
Listing DateJul 28, 2022
Issue Price5.00
Founded2018
CEODr. Vlad Vitoc, M.B.A.
MarketAMEX
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address444 West Lake Street,Suite 1700
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60606
Phone1-312-416-8592
Websitehttp://maiabiotech.com
Company Executives
- Name
- Position
- Salary
- Dr. Vlad Vitoc, M.B.A.
- Chairman of the Board, President and Chief Executive Officer
- 1.43M
- Dr. Sergei M. Gryaznov, PhD
- Chief Scientific Officer
- 894.75K
- Jeffrey Himmelreich, M.B.A.
- Head of Finance and Principal Financial and Accounting Officer
- 77.66K
- Steven M. Chaouki
- Independent Director
- 60.00K
- Ramiro Guerrero, J.D.,L.L.M.
- Independent Director
- 60.00K
- Dr. Stan V. Smith, PhD
- Lead Independent Director
- 75.00K
- Ngar Yee Louie
- Independent Director
- 90.00K
- Jean-Manasse Theagene
- Independent Director
- 47.50K
- Cristian Luput
- Independent Director
- 60.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg